chrX-154013049-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001569.4(IRAK1):c.1924G>A(p.Val642Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,208,215 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 46 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001569.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRAK1 | NM_001569.4 | c.1924G>A | p.Val642Met | missense_variant | 12/14 | ENST00000369980.8 | NP_001560.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRAK1 | ENST00000369980.8 | c.1924G>A | p.Val642Met | missense_variant | 12/14 | 1 | NM_001569.4 | ENSP00000358997.3 |
Frequencies
GnomAD3 genomes AF: 0.000651 AC: 74AN: 113625Hom.: 0 Cov.: 27 AF XY: 0.000504 AC XY: 18AN XY: 35743
GnomAD3 exomes AF: 0.000173 AC: 30AN: 173280Hom.: 0 AF XY: 0.000111 AC XY: 7AN XY: 63016
GnomAD4 exome AF: 0.0000932 AC: 102AN: 1094537Hom.: 0 Cov.: 32 AF XY: 0.0000774 AC XY: 28AN XY: 361643
GnomAD4 genome AF: 0.000651 AC: 74AN: 113678Hom.: 0 Cov.: 27 AF XY: 0.000503 AC XY: 18AN XY: 35806
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.1924G>A (p.V642M) alteration is located in exon 12 (coding exon 12) of the IRAK1 gene. This alteration results from a G to A substitution at nucleotide position 1924, causing the valine (V) at amino acid position 642 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
IRAK1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 13, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at